Globeflex Capital L P Corcept Therapeutics Inc Transaction History

Globeflex Capital L P

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$16.78 - $27.3 $1.08 Million - $1.76 Million	-64,539 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$12.46 - $19.98 $52,680 - $84,475	-4,228 Reduced 6.15%	64,539 $1.12 Million
Q2 2020 Aug 12, 2020	BUY	$11.0 - $18.26 $756,437 - $1.26 Million	68,767 New	68,767 $1.16 Million
Q2 2019 Aug 12, 2019	SELL	$9.78 - $12.76 $97,800 - $127,600	-10,000 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$10.03 - $15.71 $2,196 - $3,440	-219 Reduced 2.14%	10,000 $117,000
Q4 2018 Feb 14, 2019	SELL	$11.29 - $17.19 $226,928 - $345,519	-20,100 Reduced 66.3%	10,219 $137,000
Q3 2018 Nov 09, 2018	SELL	$12.27 - $15.65 $9,816 - $12,520	-800 Reduced 2.57%	30,319 $425,000
Q2 2018 Aug 10, 2018	SELL	$15.3 - $19.69 $1.43 Million - $1.84 Million	-93,337 Reduced 75.0%	31,119 $489,000
Q1 2018 May 14, 2018	SELL	$14.59 - $25.5 $442,077 - $772,650	-30,300 Reduced 19.58%	124,456 $2.05 Million
Q4 2017 Feb 13, 2018	SELL	$15.77 - $20.72 $1.54 Million - $2.03 Million	-97,782 Reduced 38.72%	154,756 $2.8 Million
Q3 2017 Nov 13, 2017	BUY	$12.3 - $19.3 $3.11 Million - $4.87 Million	252,538	252,538 $4.87 Million

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.3B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

Stay updated on Globeflex Capital L P with notifications on news.